Valuation: DexCom, Inc.

Market Cap 3.11TCr 18TCr 2.82TCr 2.6TCr 2.35TCr 4.43TCr 2,93000Cr 4.58TCr 31TCr 12TCr 1,56500Cr 12TCr 11TCr 4,96800Cr P/E 2026 *
32.7x
P/E 2027 * 27.6x
Enterprise Value 3.07TCr 17TCr 2.78TCr 2.58TCr 2.32TCr 4.38TCr 2,89800Cr 4.53TCr 31TCr 12TCr 1,54800Cr 12TCr 11TCr 4,91300Cr EV / Sales 2026 *
5.88x
EV / Sales 2027 * 5.23x
Free-Float
90.14%
Yield 2026 *
-
Yield 2027 * -
1 day+1.40%
1 week+7.76%
Current month+8.38%
1 month+11.32%
3 months-0.32%
6 months+62.48%
Current year+26.03%
1 week 8.46
Extreme 8.46
9.44
1 month 7.79
Extreme 7.79
9.77
Current year 5.75
Extreme 5.75
9.77
1 year 5.75
Extreme 5.75
9.77
3 years 5.75
Extreme 5.75
14.45
5 years 5.75
Extreme 5.75
18.3
10 years 5.75
Extreme 5.75
18.3
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
+1.40%+7.76% - - 3.04TCr
+1.18%-1.28%-16.05%+13.29% 19TCr
+1.85%+1.04%+6.99%+42.70% 12TCr
-0.88%-4.98%-17.08%+9.86% 12TCr
+1.36%-5.91%-43.00%+3.16% 9.14TCr
+2.96%+7.64%-1.76%+80.54% 6.67TCr
+1.08%+2.90%+12.95%-7.56% 5.88TCr
+0.89%+4.17%+0.39%+62.87% 5.5TCr
-0.68%+6.83%-1.64%+55.26% 4.99TCr
-1.28%-0.43% - - 3.51TCr
Average +0.51%-1.93%-7.40%+32.51% 9TCr
Weighted average by Cap. +0.49%-3.32%-9.99%+27.13%

Financials

2026 *2027 *
Net sales 522.84Cr 2.95TCr 473.8Cr 438.23Cr 395.4Cr 745.13Cr 49TCr 771.39Cr 5.26TCr 2.09TCr 26TCr 1.96TCr 1.92TCr 84TCr 577.48Cr 3.26TCr 523.31Cr 484.03Cr 436.72Cr 823Cr 54TCr 852.01Cr 5.81TCr 2.31TCr 29TCr 2.17TCr 2.12TCr 92TCr
Net income 98Cr 552.43Cr 89Cr 82Cr 74Cr 139.64Cr 9.24TCr 144.56Cr 986.56Cr 391.19Cr 4.94TCr 367.7Cr 359.9Cr 16TCr 114.3Cr 644.43Cr 103.58Cr 96Cr 86Cr 162.9Cr 11TCr 168.64Cr 1.15TCr 456.34Cr 5.76TCr 428.93Cr 419.83Cr 18TCr
Net Debt -34Cr -193.66Cr -31Cr -29Cr -26Cr -49Cr -3.24TCr -51Cr -345.84Cr -137.13Cr -1.73TCr -128.9Cr -126.16Cr -5.49TCr -89Cr -500.43Cr -80Cr -74Cr -67Cr -126.5Cr -8.37TCr -130.95Cr -893.7Cr -354.37Cr -4.47TCr -333.08Cr -326.02Cr -14TCr
Projected Income Statement - Annual - DexCom, Inc.
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
13/26/13 R$9.440 +3.28% 13
12/26/12 R$9.140 +2.47% 648
11/26/11 R$8.920 +0.11% 261
10/26/10 R$8.910 +0.91% 111
09/26/09 R$8.830 +0.80% 259
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - DexCom, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
83.32USD
Average target price
98.58USD
Spread / Average Target
+18.31%